Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • ascls.org
    • ascls.org

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society for Clinical Laboratory Science
  • ascls.org
    • ascls.org
  • My alerts
  • Log in
  • My Cart
American Society for Clinical Laboratory Science

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • Follow ASCLS on Twitter
  • Visit ASCLS on Facebook
  • Follow ASCLS on Instagram
  • RSS Feed
Research ArticleFocus: Healthcare-Associated Infections

The Legal Landscape: HAI Public Reporting in the United States

Julie Reagan, Rodney E. Rohde, Amber Hogan Mitchell, Marilyn Felkner and Pat Tille
American Society for Clinical Laboratory Science January 2016, 29 (1) 39-43; DOI: https://doi.org/10.29074/ascls.29.1.39
Julie Reagan
Georgia Southern University, Jiann-Ping Hsu College of Public Health, Statesboro, GA
PhD, JD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rodney E. Rohde
Clinical Laboratory Science Program, College of Health Professions, Texas State University, San Marcos, TX
CMCM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rrohde@txstate.edu
Amber Hogan Mitchell
The International Safety Center, Apopka, FL
DrPH, MPH, CPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marilyn Felkner
Emerging and Acute Infectious Disease Branch (EAIDB), Infectious Disease Control Unit, Texas Department of State Health Services (DSHS), Austin, TX
DrPH, MT(ASCP)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pat Tille
Medical Laboratory Science, College of Pharmacy, South Dakota State University, SD
PhD, MT(ASCP)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

  1. Julie Reagan, PhD, JD, MPH
    1. Georgia Southern University, Jiann-Ping Hsu College of Public Health, Statesboro, GA
  2. Rodney E. Rohde, PhD, MS, SV, SM (ASCP)CM, MBCM⇑
    1. Clinical Laboratory Science Program, College of Health Professions, Texas State University, San Marcos, TX
  3. Amber Hogan Mitchell, DrPH, MPH, CPH
    1. The International Safety Center, Apopka, FL
  4. Marilyn Felkner, DrPH, MT(ASCP)
    1. Emerging and Acute Infectious Disease Branch (EAIDB), Infectious Disease Control Unit, Texas Department of State Health Services (DSHS), Austin, TX
  5. Pat Tille, PhD, MT(ASCP)
    1. Medical Laboratory Science, College of Pharmacy, South Dakota State University, SD
  1. Address for Correspondence: Rodney E. Rohde, PhD, MS, SV, SM (ASCP)CM, MBCM, Professor & Chair, CLS Program; Associate Dean for Research, Clinical Laboratory Science Program, College of Health Professions, Texas State University, 601 University Drive, San Marcos, TX 78666, 512-245-2562, 512-245-7860, rrohde{at}txstate.edu
  1. Discuss the role of federal influences on state-level HAI program initiatives and reporting activities.

  2. Describe the progression of state-level initiatives to reduce HAIs from 2004 to the current date.

  3. Describe core provisions of state HAI reporting laws: surveillance, collection system, healthcare settings subject to the laws, types of infections reported, public reporting requirements, and advisory committee structure.

  4. Identify healthcare worker infection and illness reporting mandates.

Extract

INTRODUCTION Since early 2000, there has been a “growing interest in the use of law as a tool to address” healthcare-associated infections (HAIs) in the U.S.1 All 50 states and two territories have HAI programs established within their public health agencies.2 Likewise, the majority of states have HAI public reporting laws.3-4 HAI data is being reported from hospitals in all 50 states, either voluntarily or under state or federal legal reporting mandates.5 Additionally, while the current national focus is on reporting HAIs in the patient population, requirements for reporting infections and illness in the healthcare worker population also exists. The purpose of this article is to provide a review of the federal and state-level legal environment applicable to HAI prevention in the context of the overall response to HAIs.

Federal Influences To fully grasp state-level HAI program initiatives and reporting activities, it is important first to understand the many federal influences. Through the U.S. Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC), the federal government plays a central role in the control and prevention of HAIs. From 2004 to 2008, states began to recognize the need for state policies aimed at HAI prevention.4 Several states made significant strides toward HAI surveillance and prevention as the awareness of the public health impact of HAIs grew. However, due to budget constraints and the associated poor economic conditions starting in 2008, most states were unable to implement or further develop their HAI programs. Significant improvements…

ABBREVIATIONS: ACA – The Patient Protection and Affordable Care Act, CDC – Centers for Disease Control and Prevention, CMS – Centers for Medicare and Medicaid Services, CLABSI – central line-associated bloodstream infection, CAUTI – catheter-associated urinary tract infection, CRE – Carbepenem-resistant Enterobacteriaceae, HAIs – healthcare-associated infections, HHS – U.S. Department of Health and Human Services, IQR – Inpatient Quality Reporting Program, MRSA -- Methicillin Resistant Staphylococcus aureus, NHSN – National Healthcare Safety Network, OSHA – Occupational Safety and Health Administration, VAP – ventilator-associated pneumonia

    INDEX TERMS
  • Healthcare-associated Infections
  • HAI
  • Antibiotic Resistance
  • C. difficile
  • CDI
  • Healthcare Worker Safety
  • Multiple Drug Resistant Organisms
  • Patient Safety
  • Patient Protection and Affordable Care Act
  • Affordable Care Act
  • ACA
  • Law
  • Inpatient Quality Reporting Program
  • National Healthcare Safety Network
  • Surveillance
  1. Discuss the role of federal influences on state-level HAI program initiatives and reporting activities.

  2. Describe the progression of state-level initiatives to reduce HAIs from 2004 to the current date.

  3. Describe core provisions of state HAI reporting laws: surveillance, collection system, healthcare settings subject to the laws, types of infections reported, public reporting requirements, and advisory committee structure.

  4. Identify healthcare worker infection and illness reporting mandates.

  • © Copyright 2016 American Society for Clinical Laboratory Science Inc. All rights reserved.
PreviousNext
Back to top

In this issue

American Society for Clinical Laboratory Science: 29 (1)
American Society for Clinical Laboratory Science
Vol. 29, Issue 1
Winter 2016
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Society for Clinical Laboratory Science.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Legal Landscape: HAI Public Reporting in the United States
(Your Name) has sent you a message from American Society for Clinical Laboratory Science
(Your Name) thought you would like to see the American Society for Clinical Laboratory Science web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The Legal Landscape: HAI Public Reporting in the United States
Julie Reagan, Rodney E. Rohde, Amber Hogan Mitchell, Marilyn Felkner, Pat Tille
American Society for Clinical Laboratory Science Jan 2016, 29 (1) 39-43; DOI: 10.29074/ascls.29.1.39

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
The Legal Landscape: HAI Public Reporting in the United States
Julie Reagan, Rodney E. Rohde, Amber Hogan Mitchell, Marilyn Felkner, Pat Tille
American Society for Clinical Laboratory Science Jan 2016, 29 (1) 39-43; DOI: 10.29074/ascls.29.1.39
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The Perfect Storm: Emerging Trends and Pathogens in Healthcare
  • The Changing Role of the Healthcare Environment
Show more Focus: Healthcare-Associated Infections

Similar Articles

Keywords

  • Healthcare-associated infections
  • HAI
  • antibiotic resistance
  • C. difficile
  • CDI
  • Healthcare worker safety
  • Multiple Drug Resistant Organisms
  • Patient safety
  • Patient Protection and Affordable Care Act
  • Affordable Care Act
  • ACA
  • law
  • Inpatient Quality Reporting Program
  • National Healthcare Safety Network
  • Surveillance

© 2025 The American Society for Clinical Laboratory Science

Powered by HighWire